ArticleFrontiers in genetics2026
GAHIB: graph attention VAE with a hyperbolic information bottleneck for biologically structured single-cell representations.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current single-cell RNA-sequencing (scRNA-seq) variational autoencoders (VAEs) usually emphasise local cell graph structure, hyperbolic latent geometry, or bottleneck compression separately, yet these biases are rarely evaluated together in one evidence-gated representation model. We present GAHIB (graph attention VAE with a hyperbolic information bottleneck), which combines a graph-attention encoder, a 2D information bottleneck, and a Lorentz-hyperbolic geometry loss. Because the main clustering benchmark uses Leiden-derived proxy labels rather than definitive biological ground truth, we evaluate the model in two tiers: a broad 53-dataset proxy-label benchmark for method characterisation, and curated-label and marker analyses on annotated systems for biological interpretation. Across the proxy benchmark, GAHIB shows a balanced aggregate profile across clustering, projection-quality, and latent-structure metrics, while important comparisons remain mixed: scVI is statistically close to NMI/ARI, and scDHMap remains competitive on DRE-UMAP. On curated-label systems, the biological signal remains context-dependent; muscle atlas analyses support lineage-aligned structure with marker enrichment, whereas the fine T-cell immune-subtype task favors scVI. Sensitivity, seed-stability, a bounded count-dropout pilot, and cost analyses indicate practical runtime under the tested settings; however, the dropout evidence is limited to named pilot systems, and complete manually curated provenance remains an explicit limitation. Together, the results position GAHIB as a complementary, geometrically aware, single-cell representation rather than a drop-in clustering replacement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.